AG
AGL icon

Algert Global’s Agilon Health AGL Stock Holding History

Algert Global’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-88,224
Closed -$5.07M – 1118
2025
Q2 		$5.07M Buy
88,224
+20,425
+30% +$1.64M 0.11% 324
2025
Q1 		$7.34M Sell
67,799
-16,548
-20% -$1.44M 0.18% 161
2024
Q4 		$4.01M Buy
84,347
+76,966
+1,043% +$4.65M 0.09% 351
2024
Q3 		$725K Buy
7,381
+3,285
+80% +$424K 0.02% 823
2024
Q2 		$670K Buy
4,096
+3,274
+398% +$466K 0.02% 796
2024
Q1 		$125K Sell
822
-1,908
-70% -$317K ﹤0.01% 999
2023
Q4 		$857K Buy
2,730
+1,974
+261% +$714K 0.03% 658
2023
Q3 		$335K Sell
756
-890
-54% -$402K 0.02% 860
2023
Q2 		$713K Buy
+1,646
New +$925K 0.03% 733
2022
Q4 		– Sell
-4,400
Closed -$2.58M – 1122
2022
Q3 		$2.58M Buy
4,400
+3,475
+376% +$2.08M 0.16% 199
2022
Q2 		$505K Buy
+925
New +$468K 0.04% 756

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Algert Global's AGL Position: Q3 2025 in Review

Algert Global sold out of Agilon Health (AGL) in Q3 2025, closing a stake of 88,224 shares — an estimated $5.07M sold.

Algert Global first reported a position in AGL in Q2 2022 and held it in 11 quarters. The position peaked at $7.34M in Q1 2025. 190 funds tracked by Wall St. Rank hold AGL as of Q3 2025.

  • Algert Global reported no remaining Agilon Health position as of Q3 2025 after selling out during the quarter.
  • Algert Global sold 88,224 Agilon Health shares in Q3 2025, an estimated $5.07M.
  • Algert Global first reported a position in Agilon Health in Q2 2022 and held it in 11 quarters.
  • Algert Global's Agilon Health position peaked at $7.34M in Q1 2025.
  • 190 funds tracked by Wall St. Rank held Agilon Health as of Q3 2025.

Based on Algert Global's 13F filing for Q3 2025, filed 14 Nov 2025.